Duality Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-28,830
| Closed | -$2.78M | – | 736 |
|
2023
Q4 | $2.78M | Buy |
+28,830
| New | +$2.78M | 0.29% | 111 |
|
2023
Q3 | – | Sell |
-2,120
| Closed | -$243K | – | 705 |
|
2023
Q2 | $243K | Sell |
2,120
-17,001
| -89% | -$1.95M | 0.03% | 469 |
|
2023
Q1 | $2.64M | Sell |
19,121
-2,341
| -11% | -$323K | 0.3% | 128 |
|
2022
Q4 | $2.78M | Buy |
21,462
+19,166
| +835% | +$2.48M | 0.32% | 95 |
|
2022
Q3 | $254K | Sell |
2,296
-9,420
| -80% | -$1.04M | 0.03% | 476 |
|
2022
Q2 | $878K | Buy |
11,716
+2,965
| +34% | +$222K | 0.09% | 377 |
|
2022
Q1 | $684K | Buy |
+8,751
| New | +$684K | 0.07% | 417 |
|
2021
Q1 | – | Sell |
-5,210
| Closed | -$888K | – | 687 |
|
2020
Q4 | $888K | Buy |
5,210
+2,340
| +82% | +$399K | 0.07% | 365 |
|
2020
Q3 | $403K | Sell |
2,870
-7,553
| -72% | -$1.06M | 0.03% | 499 |
|
2020
Q2 | $1.67M | Buy |
+10,423
| New | +$1.67M | 0.15% | 191 |
|
2019
Q4 | – | Sell |
-129,950
| Closed | -$9.79M | – | 435 |
|
2019
Q3 | $9.79M | Buy |
+129,950
| New | +$9.79M | 0.55% | 38 |
|